Publication | Closed Access

Arsenic Trioxide Therapy in Relapsed or Refractory Japanese Patients with Acute Promyelocytic Leukemia: Updated Outcomes of the Phase II Study and Postremission Therapies

Hematological MalignancyOncologyHematologyRefractory Japanese PatientsArsenic Trioxide TherapyMedicineRadiation OncologyPostremission TherapiesHealth Sciences